harvard pilgrim glp 1 Tufts Health Plan, owner limiting weight-loss drug coverage Harvard Pilgrim to exclude weight

It aims to understand the common mental health side effects of semaglutide and other GLP-1 medications better

New England regional context: Blue Cross Blue Shield of Massachusetts ended weight-loss GLP-1 coverage effective January 1, 2026 a signal of regional cost pressure that members should weigh when verifying their own Harvard Pilgrim coverage

H., Alhulayfi, H

In February 2026, full results from the REDEFINE 2 study showed CagriSema achieving 23% weight loss at 84 weeks but falling short of its primary endpoint under the treatment policy estimand (which measures efficacy across all patients regardless of whether they completed treatment, rather than only those who remained on it)